Frontiers in Public Health (Jul 2022)

Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma

  • Qian Xie,
  • Hanrui Zheng,
  • Ye Chen,
  • Xingchen Peng

DOI
https://doi.org/10.3389/fpubh.2022.965798
Journal volume & issue
Vol. 10

Abstract

Read online

No abstracts available.

Keywords